Prevalence of Genetic Mutations That Predispose to Thrombophilia in a Greek Cypriot Population

Abstract

Several hereditary disorders, particularly those af fecting the physiological anticoagulation systems, have been well established as risk factors for venous thromboembolism. In the present study, we investigated the prevalence of the following thrombogenic mutations in a Greek-Cypriot popula tion : the G1691 factor V Leiden mutation, the G20210A mu tation in the prothrombin gene, and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR). All three vari ants have been documented to be significant risk factors for various cardiovascular conditions. Ninety unrelated subjects were screened. For the Leiden mutation, 11 subjects (12.2%) were heterozygous and one (1.1%) was homozygous. Seven subjects (7.8%) were heterozygous for the G20210A variant in prothrombin; no homozygotes were identified. The C677T mu tation in MTHFR was found in 40 individuals in the heterozy gous state (44.4%), and in 16 individuals in the homozygous state (17.8%). These data demonstrate that Greek-Cypriots have an increased frequency of thrombogenic mutations, and suggest that screening for these mutations should be seriously considered, especially when surgery or pregnancy is planned. This is the first study for the frequency of mutations in risk factors that predispose to thrombophilia on the island of Cyprus.

Keywords

Key Words: factor V prothrombin methylene tetrahydrofolate reductase (MTHFR)thrombophilia molecular epidemiology

References

Dahlback B. , Stenflo J. The protein C anticoagulant system. In The Molecular Basis of Blood Diseases. Stamatogiannopoulos G , Nienhuis AW , Varmus H (eds.). Philadelphia, PA: WB Saunders Company ; 1994:599.

Koster T. , Rosendaal FR , de Ronde H. , et al. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993;342:1503.

Bertina RM , Koeleman Bpc , Koster T. , et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64.

Rees DC , Cox M. , Clegg JB World distribution of factor V Leiden. Lancet 1995;346:1133.

Jackson CM Physiology and biochemistry of prothrombin. In Haemostasis and Thrombosis. Bloom AL , Forbes CD , Thomas DP , Tuddenham EGD (eds.). Edinburgh, UK: Churchill Living-stone ; 1994:397.

Poort SR , Rosendaal FR , Reitsma PH , Bertina RM A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698.

Rosendaal FR , Doggen CJ , Zivelin A. , et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998;79:706.

den-Heijer M. , Koster T. , Blom H. , et al. Hyperhomocysteinaemia is as a risk factor for deep-vein thrombosis. N Engl J Med 1996;334: 759.

Frosst P. , Blom H. , Milos R. , et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Gen 1995;10:111.

10.

Kluijtmans Laj , van den Heuvel Lpwj , Boers Ghj , et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Gen 1996; 58:35.

11.

Motulsky AG Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet 1996;58:17.

12.

Miller SA , Dykes DD , Polesky HF A simple salting out procedure for extracting DNA from human nucleated cells . Nucleic Acids Res Ser 1988;16:1215.

13.

Cumming AM , Keeney S. , Salden A. , et al. The prothrombin gene G20210A variant: prevalence in a UK anticoagulant clinic population. Br J Haem 1997;98:353.

14.

Peng F. , Triplett D. , Barna L. Evaluation of patients with thrombosis for coexistence of factor V Leiden and methylenetetrahydrofolate reductase C677T thermolabile mutation. Haemostasis 1996;26: 446a.

15.

Cattaneo M. , Tsai MY , Bucciarelli P. , et al. A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V: Q506). Blood 1996;88:285a.

16.

Seligsohn U. , Zivelin A. Thrombophilia as a multigenic disorder. Thromb Haemost 1997;78:297.

17.

Kupferminc MJ , Eldor A. , Steinman N. , et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9.